Table 1.
Difference in the lncRNA AB073614 expression in CRC patients grouped by clinicopathological characteristics
| Clinicopathological characteristics | Number of patients | Expression of lncRNA AB073614* | P-value |
|---|---|---|---|
| Sex | |||
| Male | 14 | 3.051 ± 0.5218 | 0.5393 |
| Female | 11 | 3.511 ± 0.5020 | |
| Age (year) | |||
| < 58 | 13 | 3.328 ± 0.3818 | 0.8356 |
| ≥ 58 | 12 | 3.173 ± 0.6495 | |
| Grade | |||
| I/II | 12 | 2.158 ± 0.3512 | 0.0005 |
| III/IV | 12 | 4.440 ± 0.4509 | |
| Tumor size | |||
| ≤ 5 cm | 13 | 2.082 ± 0.3320 | 0.0001 |
| > 5 cm | 12 | 4.523 ± 0.4282 | |
| Lymphatic metastasis | |||
| Yes | 12 | 3.656 ± 0.5677 | 0.2947 |
| No | 13 | 2.882 ± 0.4550 | |
| Distant metastasis | |||
| Yes | 11 | 4.500 ± 0.4776 | 0.0009 |
| No | 14 | 2.274 ± 0.3551 | |
| Differentiation | |||
| Poor | 12 | 4.285 ± 0.4964 | 0.0037 |
| High | 13 | 2.301 ± 0.3711 | |
| Vascular invasion | |||
| Yes | 11 | 3.438 ± 0.6193 | 0.6602 |
| No | 14 | 3.108 ± 0.4430 |
*
The relative expression of lncRNA AB073614 was calculated using 2-∆∆Cq method and was shown as mean ± SE.